ABSTRACT Background: A formula low-energy diet (LED) reduces weight effectively in obese patients with knee osteoarthritis, but the role of LED in long-term weight-loss maintenance is unclear. Objective: We aimed to determine the effect of intermittent LED compared with daily meal replacements on weight-loss maintenance and number of knee replacements over 3 y. Design: The design was a randomized trial with participants aged .50 y who had knee osteoarthritis and a body mass index [BMI (in kg/m 2 )] $30. Participants were recruited from the osteoarthritis outpatient clinic at Copenhagen University Hospital in Frederiksberg, Denmark; they had previously completed a 68-wk lifestyle intervention trial and achieved an average weight loss of 10.5 kg (10% of initial body weight). Participants were randomly assigned to either the intermittent treatment (IN) group with LED for 5 wk every 4 mo for 3 y or to daily meal replacements of 1-2 meals for 3 y [regular (RE) group]. Attention by dietitians and the amount of formula products were similar. Primary outcomes were changes in body weight and proportion of participants receiving knee replacements. Outcomes were analyzed on the intention-to-treat-population with the use of baseline-carried-forward imputation for missing data. Results: A total of 153 participants (means 6 SDs: BMI: 33.3 6 4.6; age: 63.8 6 6.3 y; 83% women) were recruited between June and December 2009 and randomly assigned to the IN (n = 76) or RE (n = 77) group. A total of 53 and 56 participants, respectively, completed the trial. Weight increased by 0.68 and 1.75 kg in the IN and RE groups, respectively (mean difference: 21.06 kg; 95% CI: 22.75, 0.63 kg; P = 0.22). Alloplasty rates were low and did not differ (IN group: 8 of 76 participants; RE group: 12 of 77 participants; P = 0.35). Conclusions: After a mean 10% weight-loss and 1-y maintenance, additional use of daily meal replacements or intermittent LED resulted in weight-loss maintenance for 3 y. These results challenge the commonly held assumption that weight regain in the long term is inevitable. This trial was registered at clinicaltrials.gov as NCT00938808.
INTRODUCTION
Long-term maintenance of weight loss is challenging. In patients with limited mobility and pain with knee osteoarthritis (KOA), this challenge is overwhelming. Whereas bariatric surgery is still the most durable intervention, long-term nonsurgical approaches with combinations of techniques like dietetic advice, formula low-energy products, and exercise have been shown to be highly effective (1) (2) (3) (4) . Structured eating with assistance from preportioned formula meal replacements may be feasible as weight-loss maintenance for overweight individuals who have difficulties in adjusting their energy intake with energy-dense, highly palatable, and inexpensive foods constantly available. One of the advantages of formula products is that users know exactly how many calories they have consumed, which is in contrast with conventional food, in which the energy content is typically underestimated by 40-50% (5) .
A low-energy diet (LED) is an effective, short-term treatment of both weight and KOA symptoms (6, 7) . Weight loss is strongly recommended as primary management of concomitant obesity and KOA (8) (9) (10) (11) . However, no study to our knowledge has yet assessed how to use low-energy formula diet products as a means of long-term weight-loss maintenance in both KOA and other populations. Thus, the optimal long-term delivery of such intervention with respect to both weight maintenance and important KOA outcomes remains unclear.
The purpose of the LIGHT (long-term intervention with weight loss in patients with concomitant obesity and KOA) study was to compare the long-term (3-y) clinical efficacy and safety profiles of 2 active weight-loss maintenance interventions: 1) 3 annual intensive 5-wk periods of LED and counseling for 3 y, and 2) daily replacement of 1-2 meals with a formula diet product and counseling every 3 wk for 3 y. The participants used a similar amount of LED products and had the same amount of attention from dietitians in both interventions. Our hypothesis was that a regular strategy would lead to a safer and more sustained weight-loss maintenance than an intermittent strategy. Also, we were interested in testing the unresolved concerns about weight cycling (12) .
METHODS

Study design
The LIGHT study is a prospective, randomized, parallelgroup, 3-y trial. We recruited participants from the osteoarthritis outpatient clinic at Copenhagen University Hospital at Frederiksberg, Denmark. We compared the effects of reduction in energy intake by intermittent use of LED and use of daily meal replacements in adults with concomitant KOA and obesity [BMI (in kg/m 2 ) $30] for the purpose of maintaining a previously achieved weight loss.
Ethical approval for this trial was granted by the regional research ethics committee of the Capital Region of Denmark, reference H-B-2009-029, on 28 May 2009. Subjects were recruited between June and December 2009. Due to an administrative oversight, registration of the trial occurred a month late on 13 July 2009 at clinicaltrials.gov (NCT00938808). The protocol is available from the corresponding author.
Participants
Participants were eligible for inclusion if they had completed the final follow-up visit in the previous CAROT (Influence of Weight Loss or Exercise on Cartilage in Obese Knee Osteoarthritis Patients Trial) study, in which a significant weight loss was induced over 16 wk (6, 7) and aimed at being maintained over the subsequent 52 wk (13, 14) . Eligibility criteria were age of $50 y, radiographically confirmed KOA (15) , and obesity (BMI $30). Participants were considered ineligible if they had bilateral total knee alloplasty (TKA), were not motivated for maintaining achieved weight loss, were in pharmacologic antiobesity treatment, or had acquired a medical condition that, as judged by the investigator, precluded participation in the interventions by putting participants at unacceptable risk or difficulty in complying with the protocol, such as malignancy or recent surgical procedure without full convalescence. Details and results from the CAROT study have been published (6, 7, 13, 14, 16) .
Randomization
Participants were randomly assigned with the use of minimization with an equal allocation ratio (1:1) to increase the likelihood of balance of prognostic factors of the participants in each of the 2 groups. The minimization model was probabilistic without criteria for a maximal amount of imbalance between factors not included in the model. The participants were stratified according to sex, previous group (diet, exercise, or control), and initial BMI category (30-34.9, 35-39.9, and $40). The concealed allocation was done for all the participants entering the study at baseline. Each randomization list was drawn up by the biostatistician (RC) and given to the administrative staff at the Parker Institute, who informed the participant to which group they were randomly assigned. The random assignment prevented knowledge of forthcoming allocations by study participants and personnel recruiting participants to the trial.
Procedures
Participants were recruited to the LIGHT study from June to December 2009. Potentially eligible participants received oral and written information about the study and were invited to a clinical examination by a rheumatologist. After giving consent, participants were randomly assigned in the manner described above to intermittent use of LED or daily use of meal replacements assisted with dietary group counseling.
Both interventions were group-based dietary and behavioral interventions led by a dietitian (18 visits/y) focusing on weight loss and maintenance. Formula weight loss products were used in both interventions with different strategies. The principal goal of the interventions was for the participants to maintain (or enhance) the weight loss achieved during participation in the CAROT study.
Intermittent group
The participants in the intermittent treatment (IN) group were offered 3 intensive weight loss periods/y, each lasting 5 wk, during which participants were provided with meal replacement products [Cambridge Weight Plan (Cambridge Weight Plan Ltd.) consisting of an all-provided LED with 3400 kJ/d (810 kcal/d)]. The program met recommendations for daily intake of essential nutrients, including amino acids, vitamins, and minerals. During the 5-wk periods, participants attended weekly group sessions (1 h) with the dietitian (for weighing and motivational advice on successful weight loss and maintenance) and 1 session in between the intensive periods. If participants were motivated for additional weight loss between the intensive periods, they were advised to eat a diet of w5000 kJ/d (1200 kcal/d) of self-selected healthy conventional food, and otherwise, they were guided how to maintain weight. The last LED period ended 12 wk before the 3-y assessment. The last group session was scheduled 6 wk before the 3-y assessment.
Regular group
The participants in the regular (RE) group were offered the use of 1-2 formula diet products daily throughout the 3 y, thereby reducing the daily energy intake by substituting 1-2 meals. Besides the use of daily meal replacements, group sessions were scheduled every third week. The themes in the dietetic sessions offered were similar to those offered to the IN group. Participants who had already reached their target weight would substitute 1 main meal/d, whereas participants who wanted to lose additional weight substituted 2 meals/d. The last group session was scheduled for 1 wk before the 3-y assessment.
The total use of formula products was the same for the IN and RE intervention arms, by design; this was also true for attention from dietitians.
Outcomes
Outcomes were measured at baseline (before randomization), 1 y after randomization, and after 3 y. The 2 primary outcomes were change in body weight after 3 y and the number of participants who received a TKA during the 3-y intervention; however, receiving TKA during the study was not a criterion for individual study discontinuation. At the outcome assessment visits, body weight was measured on a digital scale (TANITA BW-800) in the morning before food intake by a study nurse blinded to group allocation. The study dietitians (not blinded) also recorded body weight at each counseling session during the 3-y intervention (18 recordings/y). Not all dietary counseling sessions were in the morning; thus, these body weight records were not necessarily taken in a fasting state.
TKA incidence was obtained by patient reporting and confirmed by dual energy X-ray absorptiometry scans. Participants who did not attend the follow-up visits were contacted by phone, and the evidence of TKA surgery was gathered from hospital files. When evaluating the occurrence of serious adverse events (SAEs) during the study, the same process was applied for a follow-up period of 1 y after the study had ended (4 y in total). The adverse events were self-reported with the use of a questionnaire at the follow-up visits.
Secondary outcomes included waist circumference, lean body mass, fat mass, bone mineral content, and bone mineral density, determined by dual energy X-ray absorptiometry with the use of a Lunar DPX IQ Full Body Bone Densitometer (GE Medical Systems), as well as blood pressure measured with the use of a mercury sphygmomanometer. In addition, the Knee Injury and Osteoarthritis Outcome Score (KOOS) (17) was used to assess patient important KOA outcomes. KOOS is a self-administered questionnaire covering 5 dimensions: pain, symptoms, activity of FIGURE 1 Screening, randomization, and follow-up of study participants. Primary outcomes included the week 156 assessment (3 y from baseline). ITT, intention-to-treat. daily living, sport and recreation function, and knee-related quality of life, each scored on a 0-100 scale (100 is the best). Fasting blood samples were analyzed for standard biochemical variables related to cardiovascular disease risk with the use of standard laboratory procedures. Finally, we classified participants with metabolic syndrome (MS) with the use of the Joint Scientific Statement definition (18) .
Statistical analysis
The LIGHT study was designed as a superiority trial, with the expectation that the RE group would maintain their weight and the IN group would gain weight. Because the eligibility criteria for participation included completion of the preceding study, no prospective sample size calculation was performed. However, we expected a priori that $150 individuals completing the CAROT study would be interested in participation, resulting in 86% power to detect a group difference in weight of $3 kg (pooled SD = 6 kg) after 3 y.
The main statistical analyses were performed on the intentionto-treat population, including all randomly assigned participants and replacing missing data with the baseline observation (19) .
Continuous data were analyzed for group differences in the changes from baseline at the 1-and 3-y follow-up visits separately with the use of ANCOVA, adjusting for the baseline value. In addition, because there are many historical data on the participants, we adjusted for the outcomes before baseline and allocations in the preceding CAROT study (6, 14) . Count data, such as numbers of patients receiving a TKA, fulfilling the MS criteria, and regaining .5% of weight, were analyzed for group differences by simple 2 3 2 contingency tables and x 2 (or Fisher's exact test when expected cell counts were ,5). The x 2 test is only valid when the data set is large enough with a reasonable number of expected counts (i.e., depending on the marginal totals); sample sizes are too small when .20% of the contingency cells have expected values ,5.
Sensitivity analyses were performed on continuous data with the use of the multiple imputation technique for missing data. We created 100 imputed data sets with missing data imputed with the use of linear regression with age, sex, group allocation, baseline weight, and baseline value as predictors. Derived and calculated variables (e.g., the number of participants with MS) were not imputed because these are based on variables that have been imputed independently. The coprimary outcome, TKA incidence, was not imputed because there were no missing data. Additional sensitivity analyses were done on the as-observed population (i.e., no imputation of missing data).
To explore the body weight trajectories over the 3-y study period, we analyzed the body weight records obtained at the group sessions with the use of a repeated mixed linear model, including participants as a random effect with fixed factors for groups (2 groups; IN group compared with RE group) and visits (54 visits) and their interaction. This analysis was done on the available case population (i.e., no imputation of missing data).
This trial is registered at clinicaltrials.gov with identifier NCT00938808 and has been completed.
RESULTS
A total of 159 participants completed the preceding CAROT study (14) . Of these, 6 declined participation in this subsequent study, resulting in 153 being randomly assigned (Figure 1 Table 1 . At baseline, the mean weight loss of participants was 10.3 and 10.6 kg (SDs: 7.4 and 7.6 kg) in the IN and RE groups, respectively. Sixteen participants entered the study with a TKA in 1 knee (equally distributed between groups).
In total, 109 completed this 3-y weight maintenance study (71.2%), with similar dropout rates in the 2 groups (23 of 76 participants in the IN group compared with 21 of 77 participants in the RE group). The most common reasons for dropout were loss of motivation and problems with combining work hours with the scheduled meetings.
The changes after 3 y in body weight and incidence of TKA are presented in Table 2 . The group difference in the change in body weight was 21.06 kg (95% CI: 22.75, 0.63 kg; P = 0.22). The cumulated incidence of TKA over the 3-y period was 8 participants (10.5%) in the IN group and 12 participants (15.6%) in the RE group, with no statistically significant difference between groups [5.1% (95% CI: 25.6%, 15.7%); P = 0.35].
The changes from baseline in secondary outcomes are also presented in Table 2 . There were no statistically significant group 1 Values are mean changes (95% CIs) unless otherwise indicated. Between-group differences in changes in continuous data were analyzed with the use of ANCOVA, adjusting for the baseline value. In addition, an adjustment for the outcomes before baseline and allocations in the preceding CAROT study was performed. Count data, such as numbers of patients receiving a TKA, fulfilling the metabolic syndrome criteria, and regaining .5% of weight were analyzed for group differences by simple 2 3 2 contingency tables and x 2 (or Fisher's exact test when expected cell counts were ,5). CAROT, Influence of Weight Loss or Exercise on Cartilage in Obese Knee Osteoarthritis Patients Trial; CVD, cardiovascular disease; HbA1c, glycated hemoglobin; KOOS, Knee Injury and Osteoarthritis Outcome Score; TKA, total knee arthroplasty. 2 Metabolic syndrome is defined with the use of the Joint Scientific Statement definition (18) . In the table, we report the absolute number of participants with the classification. differences in any of the secondary outcomes. A higher proportion of RE participants had gained .5% weight after 3 y (12 compared with 22 participants), although this difference did not quite reach statistical significance [12.8% (95% CI: 20.2%, 25.8%); P = 0.08].
The sensitivity analyses (multiple imputation and as observed) changed the estimates slightly, but did not change the statistical results or interpretation (Supplemental Table 1 and 2).
The outcomes at the 1-y assessment are presented in Supplemental Table 3 and show a statistically significant group difference in weight maintenance of 22.55 kg (95% CI: 24.42, 20.86 kg; P = 0.003) in favor of the IN group that was stable, whereas the RE group increased body weight slightly. Statistically significant group differences in favor of the IN group with respect to changes in waist circumference and fat mass support this observation at the 1-y assessment. There were no group differences in the remaining secondary outcomes after 1 y.
The body weight trajectories recorded by the dietitians over the 3-y study period are illustrated in Figure 2 . The statistical analysis of the trajectories showed a statistically significant interaction between week and group (P , 0.0001), indicating a clear difference in weight patterns between the 2 groups, corresponding to the mean body weight across all 3 y being statistically significantly in favor of the IN group compared with the RE group [1.8 kg (95% CI: 0.6, 3.0 kg); P = 0.0032]. Table 3 shows the adverse and SAEs during the trial period. Influenza was significantly more common in the RE group, whereas bad breath was more common in the IN group. No other reported adverse events showed statistically significant differences between the groups.
DISCUSSION
This study was designed to compare the long-term efficacy of 2 different weight-loss maintenance strategies among adults with KOA. This study is the first, to our knowledge, to assess longterm efficacy of weight-loss maintenance in KOA patients on changes in body weight, KOA outcomes, body composition, and markers of cardiovascular disease risk. We found comparable long-term benefits and safety of daily meal replacements and intermittent use of LED on all outcomes.
There are several important aspects of our results. First, longterm obesity management with dietary approaches has generally been considered unsuccessful and a waste of time that, for most people, likely results in complete weight regain (20) . Our results show only minor weight regain over 3 y and thus support the application of long-term meal replacement use and counseling, with comparable efficacy and safety of regular and intermittent strategies.
Second, our study provides evidence against the concerns about weight cycling, which health care practitioners believe to be associated with untoward changes in body composition and increased cardiometabolic risk (21-24). Mehta et al. (25) reviewed 13 literature definitions of weight cycling, and most referred to changes of .5% or .4.5 kg. The amplitude of cycling in our study was 2-2.5 kg (,3% baseline body weight). Although the IN group was advised to use the 3 annual LED periods for weight loss and to maintain or increase weight loss in between the LED periods, the body weight trajectories ( Figure  2 ) clearly show another pattern. Our results are based on a randomized study design, and we found no indications of harmful effects either from weight cycling or the more steady weight management strategy. Thus, our long-term study results do not support the presumed weight-cycling concerns.
Third, our study provides the first long-term data on weightloss maintenance and its clinical efficacy in KOA patients. It was an important aim to improve or maintain the KOA-related symptom responses achieved by the initial weight loss (14) and prevent TKA. All patient-reported symptom responses were stable during this study, with no group differences. In addition, the 95% CIs of the changes within groups and the between group differences cover the suggested minimally important difference of 8-10 KOOS points that correspond to practical equivalence margins used previously (26) . We therefore consider the intervention strategies comparable and highly effective for symptomatic maintenance for 3 y. Similarly, a relatively low incidence of TKA (13%) was noted without group differences. This finding is in accordance with recent results of nonsurgical treatments as a relevant alternative to TKA, which may be delayed or even avoided in a large proportion of patients with KOA (27) . Weight loss is highlighted unanimously in international guidelines on KOA management (9-11), but until now, no recommendations have been given regarding means of weight-loss maintenance. These results provide support for clinical decisionmaking and guidance.
Very few safety issues were encountered during our study, and there were no differences between the groups regarding SAEs, including the TKAs. Among the other adverse events, only differences in frequency for complaints of bad breath and flu-like symptoms were noted. The former might be related to differences in diet between the groups, but, we have no explanation for the higher frequency of flu-like symptoms in the RE group.
One limitation of our study is that during the group sessions with dietitians, the participants were not necessarily weighed in the fasting state because the sessions took place at different hours during the day. This limitation could have influenced the body weight trajectories results presented in Figure 2 , however, because the sessions were similarly distributed between the 2 groups, we expect the impact on the results to be rather small. In addition, we had no control group with usual care therapy with which to compare the 2 active interventions. However, we decided to design the study with no control group because we believed it would be unethical not to offer an active intervention to all participants, having in mind the evidence concerning weight loss and KOA symptoms. There are no available data on the effect of standard care, however, based on our professional experience throughout the years, weight loss is unfortunately very difficult to maintain in this group of patients. In general, standard care by general practitioners providing weight loss management in Denmark has been shown to produce no weight loss over 3-6 mo. 1 Values are n (%). Serious adverse events that occurred up to and including week 208 after baseline among patients in the safety analysis. Events were classified by their preferred terms from the Medical Dictionary for Regulatory Activities and pooled into the listed groups. Events are included if they had an onset date on or after the first day of the study intervention after the informed consent form was signed and at #52 wk after the last investigation day of the study.
2 P , 0.05. 3 Intermittent group, n = 76; regular group, n = 77. 4 The adverse events were scrutinized by the primary investigator, who considered the possible relation with the study intervention without knowledge of group allocation. Included were the total knee alloplastic surgeries and later complications to these operations and some gastrointestinal events (e.g., gall bladder problems).
In conclusion, this long-term weight maintenance study of obese individuals with KOA demonstrates that a structured formula diet strategy for weight maintenance in combination with dietary counseling, either as daily meal replacements with counseling every 3 wk or a strategy with intermittent 5-wk LED periods with weekly counseling during the periods, lead to comparable, successful, and safe outcomes after 3 y. The weight loss-induced benefits on cardiovascular disease risk profiles and osteoarthritis symptoms did not regress over 3 y and no adverse effects of weight cycling of ,3% of body weight were observed over the course of 3 y when compared with the regular strategy.
Our results are clinically important and relevant because they demonstrate that it is possible to support older patients with KOA in maintaining a 10% body weight loss in the long term, challenging the commonly held assumption that weight regain in the long term with concomitant health detriments is inevitable.
